Regeneron Pharmaceuticals Inc. Stock Outperforms Market Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 2.55% to $688.08 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 2.77% to 4,271.78 and Dow Jones Industrial Average falling 2.82% to 33,811.40. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $59.34 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.99% to $181.54, Novartis AG ADR (NOVN.EB) fell 0.82% to $89.21, and Amgen Inc. (AMGN) fell 2.00% to $250.35. Trading volume (609,374) remained 55,939 below its 50-day average volume of 665,313.
Data source: Dow Jones Market Data, FactSet. Data compiled April 22, 2022.
-MarketWatch Automation
(END) Dow Jones Newswires
April 22, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.